Meeting
2019 Genitourinary Cancers Symposium
Predictors of positive lesions in 18F-fluciclovine PET/CT.
Authors
Helen Y Hougen
Oregon Health and Science University Department of Urology, Portland, OR
Helen Y Hougen , Nadine Mallak , Yiyi Chen , Catherine Degnin , Ryan P Kopp , Jen-Jane Liu , Sudhir Isharwal , Arthur Hung
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 231)
DOI
10.1200/JCO.2019.37.7_suppl.231
Abstract #
231
Poster Bd #
K10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of MRI and targeted biopsy on oncological outcomes of prostate cancer after treatment.
First Author: Neha Debnath
Poster
2022 ASCO Genitourinary Cancers Symposium
BCG efficacy in nonmuscle-invasive bladder cancer after prior radiation treatment for prostate cancer.
First Author: Adri Durant
Poster
2019 ASCO Annual Meeting
A phase II Salvage Trial of AR Inhibition with ADT and Apalutamide with Radiation therapy followed by docetaxel in men with PSA recurrent prostate cancer (PC) after radical prostatectomy (STARTAR).
First Author: Tian Zhang
Poster
2017 Genitourinary Cancers Symposium
Short- and long-term outcomes of salvage lymph node dissection in patients with clinically recurrent prostate cancer.
First Author: Giorgio Gandaglia